A unique collection of 1200 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); Bioactivity and safety confirmed by pre-clinical research evidence and clinical trials; An effective tool for discovering new with old drugs and new drug target identification; Covers various research areas: oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc Structurally diverse, medicinally active, and cell permeable; Rich documentation with structure, target, IC50 value and biological activity description; NMR and HPLC/LCMS validated to ensure high purity